Luxfer (LXFR) Stock Declines on Q4 2024 Results

Author's Avatar
Feb 26, 2025
Article's Main Image

Shares of specialty material and gas containment company Luxfer (LXFR, Financial) have seen a significant decline of 9.18% after the company released its Q4 2024 financial results. The drop was due to the full-year revenue and EBITDA guidance, which did not meet analysts' expectations. The current stock price is $12.56.

Despite the disappointing guidance, Luxfer (LXFR, Financial) demonstrated a strong quarterly performance with revenue, EPS, and EBITDA surpassing analysts' estimates. The company's P/E ratio stands at 18.47, indicating a reasonably priced valuation compared to the industry average. The company's market capitalization is $336.42 million. Luxfer's (LXFR) current P/B ratio is 1.53, suggesting the stock is trading at a slight premium to its book value.

Luxfer Holdings PLC continues to focus on niche applications in materials engineering, creating value through innovative technology. The company has shown solid financial strength, as reflected by its strong Altman Z-score of 3.32 and a high Piotroski F-Score of 7, indicating a healthy financial position. Moreover, the Beneish M-Score of -2.7 suggests that the company is unlikely to be manipulating its financials.

The GF Value of Luxfer (LXFR, Financial) is assessed as "Fairly Valued," with a GF Valuation of $13.68. This valuation is available on GF Value. Shareholders can take comfort in the robust shareholder yield of 10.36%, which is competitive compared to industry standards. However, investors should be cautious due to the company's medium-level warning signs, such as declining revenue per share and a gross margin trend.

In conclusion, Luxfer's (LXFR, Financial) recent financial performance highlights both strengths and challenges. While the quarterly results are promising, the lower-than-expected full-year guidance necessitates a careful evaluation for potential investors. The stock's current metrics suggest it is fairly valued, and its strong financial health indicators could offer potential for long-term growth.

Disclosures

I/We may personally own shares in some of the companies mentioned above. However, those positions are not material to either the company or to my/our portfolios.